Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03490097
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03490097
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT03490097. Randomized; double masking; primary purpose treatment. Start 2017-12-01 (actual); primary completion 2018-05-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination
- Condition
- Chronic Hepatitis c
- Condition
- Metabolic Syndrome
- Intervention (Drug)
- Simvastatin 10mg
- Intervention (Drug)
- sofosbuvir plus daclatasvir
- Lead sponsor
- Ain Shams University
Record details
- Record id
cardio:ct-nct03490097- Content hash
4a856328e96952ffe0edc35268d1a29367c70c759ef533021bc6ec029bf7243d